The immune profile associated with acute allergic asthma accelerates clearance of influenza virus

Immunology and Cell Biology

Volumn 92, Issue 5, 2014, Pages 449-459

  Samarasinghe, Amali E ^a,b,c   Woolard, Stacie N ^a,b   Boyd, Kelli L ^d   Hoselton, Scott A ^e   Schuh, Jane M ^e   Mccullers, Jonathan A ^a,b,c  

^a Department of Infectious Diseases ^*  (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

acute asthma; airway epithelium; chronic asthma; comorbidity; mouse model

Indexed keywords

INTERFERON; SOMATOMEDIN C;

AIRWAY REMODELING; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; COMORBIDITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EOSINOPHILIA; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNE STATUS; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; MOUSE; MUCUS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REPLICATION; WEIGHT REDUCTION; ACUTE DISEASE; ANIMAL; ASTHMA; CHRONIC DISEASE; DISEASE MODEL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; RESPIRATORY TRACT MUCOSA; VIROLOGY;

ASPERGILLUS FUMIGATUS; MURINAE; MUS; ORTHOMYXOVIRIDAE;

ACUTE DISEASE; ANIMALS; ASTHMA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERFERONS; MICE; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY MUCOSA;

EID: 84901679097     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.113     Document Type: Article

References (56)

1. WHO. Asthma. 2011 ASthma Fact Sheet. Available at http://www.who.int/ mediacentre/ factsheets/fs307/en/index.html (cited 29 July 2013, last accessed on 29 July 2013
2. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G et al. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR 2009; 58: 1-52
3. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-1944
4. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010; 65: 645-651
5. Eriksson CO, Graham DA, Uyeki TM, Randolph AG. Risk factors for mechanical ventilation in US children hospitalized with seasonal influenza and 2009 pandemic influenza A.. Pediatr Crit Care Med 2012; 13: 625-631
6. Tran D, Vaudry W, Moore DL, Bettinger JA, Halperin SA, Scheifele DW et al. Comparison of children hospitalized with seasonal versus pandemic influenza A, 2004-2009. Pediatrics 2012; 130: 397-406
7. Gilca R, De Serres G, Boulianne N, Ouhoummane N, Papenburg J, Douville-Fradet M et al. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respir Viruses 2011; 5: 247-255
8. McKenna JJ, Bramley AM, Skarbinski J, Fry AM, Finelli L, Jain S. Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection - United States, 2009. BMC Infect Dis 2013; 13: 57
9. Semple M, Myles P, Enstone J, Openshaw P, Read R, Taylor B et al. The Relationship of Asthma to Outcome in Influenza A/H1N1 2009 Infections: FLU-CIN Cohort Study. European Respiratory Society, Amsterdam, The Netherlands, 2011
10. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12: 631-638
11. Hoselton SA, Samarasinghe AE, Seydel JM, Schuh JM. An inhalation model of airway allergic response to inhalation of environmental Aspergillus fumigatus conidia in sensitized BALB/c mice. Med Mycol 2010; 48: 1056-1065
12. Samarasinghe AE, Hoselton SA, Schuh JM. A comparison between intratracheal and inhalation Delivery of Aspergillus fumigatus conidia in the development of fungal allergic asthma in C57BL/6 mice. Fungal Biol 2011; 115: 21-29
13. Ostransky D, Blais FX. Postviral bronchial hyperreactivity syndrome: Recognizing asthma's great mimic. J Am Osteopath Assoc 1991; 91: 465-468. 471-465
14. Hsu HC, Zhang HG, Li L, Yi N, Yang PA, Wu Q et al. Age-related thymic involution in C57BL/6J-DBA/2J recombinant-inbred mice maps to mouse chromosomes 9 and 10. Genes Immun 2003; 4: 402-410. (Pubitemid 38967605
15. Yin L, Xu S, Cheng J, Zheng D, Limmon GV, Leung NH et al. Spatiotemporal quantification of cell dynamics in the lung following influenza virus infection. J Biomed Opt 2013; 18: 046001
16. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001; 12: 171-180. (Pubitemid 32588143
17. Chang YJ, Kim HY, Albacker LA, Lee HH, Baumgarth N, Akira S et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest 2011; 121: 57-69
18. Yamamoto N, Suzuki S, Suzuki Y, Shirai A, Nakazawa M, Suzuki M et al. Immune response induced by airway sensitization after influenza A virus infection Depends on timing of antigen exposure in mice. J Virol 2001; 75: 499-505
19. Samarasinghe AE, Hoselton SA, Schuh JM. The absence of the VPAC(2) receptor does not protect mice from Aspergillus induced allergic asthma. Peptides 2010; 31: 1068-1075
20. Wanzeck K, Boyd KL, McCullers JA. Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med 2011; 183: 767-773
21. Ishikawa H, Sasaki H, Fukui T, Fujita K, Kutsukake E, Matsumoto T. Mice with asthma are more resistant to influenza virus infection and NK cells activated by the induction of asthma have potentially protective effects. J Clin Immunol 2012; 32: 256-267
22. Papadopoulos NG, Christodoulou I, Rohde G, Agache I, Almqvist C, Bruno A et al. Viruses and bacteria in acute asthma exacerbations - a GA(2) LEN-DARE systematic review. Allergy 2011; 66: 458-468
23. Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, Roberg KA et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med 2012; 185: 1275-1279
24. Parker D, Prince A. Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol 2011; 45: 189-201
25. Bals R, Hiemstra PS. Innate immunity in the lung: How epithelial cells fight against respiratory pathogens. Eur Respir J 2004; 23: 327-333. (Pubitemid 38195522
26. Chan RW, Yuen KM, Yu WC, Ho CC, Nicholls JM, Peiris JS et al. Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS One 2010; 5: E8713
27. LN H, SA M, ER U, WE G. Interleikin-1 is linked to the respiratory epithelial cytopathology pf pertussis. Infect Immun 1993; 61: 3123-3128
28. Becnel D, You D, Erskin J, Dimina DM, Cormier SA. A role for airway remodeling during respiratory syncytial virus infection. Respir Res 2005; 6: 122
29. Riesenfeld E, Allen GB, Bates JH, Poynter ME, Wu M, Aimiand S et al. The temporal evolution of airways hyperresponsiveness and inflammation. J Allergy Ther 2012; 1: 1-7
30. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997; 185: 2143-2156. (Pubitemid 27265998
31. Kobayashi T, Iijima K, Kita H. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J Immunol 2003; 170: 5756-5763. (Pubitemid 36617869
32. Tsukagoshi H, Sakamoto T, Xu W, Barnes PJ, Chung KF. Effect of interleukin-1 beta on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats. J Allergy Clin Immunol 1994; 93: 464-469
33. Tomlinson KL, Davies GC, Sutton DJ, Palframan RT. Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite. PLoS One 2010; 5: 10
34. Pothen JJ, Poynter ME, Bates JH. The inflammatory twitch as a general strategy for controlling the host response. J Immunol 2013; 190: 3510-3516
35. Tate MD, Deng YM, Jones JE, Anderson GP, Brooks AG, Reading PC. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 2009; 183: 7441-7450
36. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. Virus-specific CD8 T cells in primary and secondary influenza pneumonia. Immunity 1998; 8: 683-691
37. Abraham D, Rotman HL, Haberstroh HF, Yutanawiboonchai W, Brigandi RA, Leon O et al. Strongyloides stercoralis: Protective immunity to third-stage larvae inBALB/cByJ mice. Exp Parasitol 1995; 80: 297-307
38. Shi HZ, Humbles A, Gerard C, Jin Z, Weller PF. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest 2000; 105: 945-953. (Pubitemid 30203067
39. Cohen SG, Sapp TM. Phagocytosis of bacteria by eosinophils in infectious-related asthma. J Allergy 1969; 44: 113-117
40. Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, Rosenberg HF et al. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 2007; 110: 1578-1586. (Pubitemid 47443974
41. Ueki S, Melo RC, Ghiran I, Spencer LA, Dvorak AM, Weller PF. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood 2013; 121: 2074-2083
42. Wohlleben G, Muller J, Tatsch U, Hambrecht C, Herz U, Renz H et al. Influenza A virus infection inhibits the efficient recruitment of Th2 cells into the airways and the development of airway eosinophilia. J Immunol 2003; 170: 4601-4611. (Pubitemid 36519966
43. Wohlleben G, Erb KJ. The absence of IFN-gamma leads to increased Th2 responses after influenza A virus infection characterized by an increase in CD4 but not CD8 T cells producing IL-4 or IL-5 in the lung. Immunol Lett 2004; 95: 161-166. (Pubitemid 39237661
44. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD. CCR2 monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 2008; 180: 2562-2572
45. Trinchieri G. Type I interferon: Friend or foe?. J Exp Med 2010; 207: 2053-2063
46. Levraud JP, Boudinot P, Colin I, Benmansour A, Peyrieras N, Herbomel P et al. Identification of the zebrafish IFN receptor: Implications for the origin of the vertebrate IFN system. J Immunol 2007; 178: 4385-4394. (Pubitemid 46492389
47. Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci USA 2011; 108: 7944-7949
48. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: An overview of signals, mechanisms and functions. J Leuk Biol 2004; 75: 163-189. (Pubitemid 38174573
49. Yamashita N, Tashimo H, Ishida H, Matsuo Y, Arai H, Nagase H et al. Role of insulinlike growth factor-I in allergen-induced airway inflammation and remodeling. Cell Immunol 2005; 235: 85-91. (Pubitemid 41597471
50. Butt AJ, Firth SM, Baxter RC. The IGF axis and programmed cell death. Immunol Cell Biol 1999; 77: 256-262. (Pubitemid 29251579
51. Smith TJ. Insulin-like growth factor-I regulation of immune function: A potential therapeutic target in autoimmune diseases?. Pharmacol Rev 2010; 62: 199-236
52. Baudler S, Baumgartl J, Hampel B, Buch T, Waisman A, Snapper CM et al. Insulin-like growth factor-1 controls type 2 T cell-independent B cell response. J Immunol 2005; 174: 5516-5525. (Pubitemid 40593192
53. Grunberg K, Sharon RF, Sont JK, In 't Veen JC, Van Schadewijk WA, De Klerk EP et al. Rhinovirus-induced airway inflammation in asthma: Effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Critic Care Med 2001; 164(Part 1), 1816-1822
54. LaRussa P. Pandemic novel 2009 H1N1 influenza: What have we learned?. Semin Respir Crit Care Med 2011; 32: 393-399
55. Fowlkes AL, Arguin P, Biggerstaff MS, Gindler J, Blau D, Jain S et al. Epidemiology of 2009 pandemic influenza A (H1N1) deaths in the United States, April-July 2009. Clin Infect Dis 2011; 52(Suppl 1), S60-S68
56. Bush A, Menzies-Gow A. Phenotypic differences between pediatric and adult asthma. Proc Am Thorac Soc 2009; 6: 712-719 Diseases